Global Health Chart
Global Health Share Key Metrics
Volume
75688.00
Market Cap
29706.71 CR
LTQ@LTP
2@1105.20
ATP
1111.03
Var Margin
15.86 %
Circuit Range
884.2-1326.2
Delivery %
52.45 %
Value
8.41 CR
ASM/GSM
No
Market Lot
1
Summary
Global Health Fundamentals
View MoreP/E Ratio
57.87
P/B Ratio
7.82
Div. Yield
0.05
Sector P/E
54.08
Sector P/B
-16.4
Sec. Div. Yield
2.46
Global Health Resistance and Support
Pivot 1106.77
Resistance
First Resistance
1123.44
Second Resistance
1141.67
Third Resistance
1158.34
Support
First Support
1088.54
Second Support
1071.87
Third Support
1053.64
Global Health Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-04 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-04 | Quarterly Results |
Global Health News
Global Health Q2 Results: Medanta operator posts 5% rise in net profit YoY at Rs 131 crore
Nov 14 2024 19:51:59
About Global Health
NSE : 11956
BSE : 543654
ISIN : INE474Q01031
Our Company was incorporated as ‘Global Health Private Limited’ on August 13 2004 at New Delhi India as a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act 2013 pursuant to a special resolution passed by our Shareholders in the EGM held on July 31 2021 and consequently the name of our Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e. Investor Selling Shareholder) invested in our Company-1st Joint Commission International (“JCI”) accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary GHPPL entered into a 33-year concession agreement with Governor of Bihar for the development operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital’s outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital’s inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy
Global Health Management
| Name | Position |
|---|---|
| Dr. Naresh Trehan | Chairman & Managing Director |
| Mr. Sunil Sachdeva | Non Executive Director |
Global Health Similar Stocks
Anthem Biosciences Ltd.
670.15
0.00 (0.00%)
Ajanta Pharma Ltd.
2999.90
0.00 (0.00%)
Narayana Hrudayalaya Ltd.
1750.50
0.00 (0.00%)
Aster DM Healthcare Ltd.
665.50
0.00 (0.00%)
JB Chemicals & Pharmaceuticals Ltd.
2117.40
0.00 (0.00%)
Emcure Pharmaceuticals Ltd.
1567.80
0.00 (0.00%)
Krishna Institute of Medical Sciences Ltd
688.50
0.00 (0.00%)
Gland Pharma Ltd.
1688.20
0.00 (0.00%)
Dr. Lal Pathlabs Ltd.
1378.20
0.00 (0.00%)
Pfizer Ltd.
4807.50
4.00 (0.08%)
Global Health FAQs
